Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Takemi Tanaka

Showing results (21-30 of 45) with videos related to

Pageof 5
Sort By:
Journal of Biomedical Materials Research. Part A|August 10, 2010
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylationBiana Godin, Jianhua Gu, Rita E Serda, et al.
Plos One|October 8, 2010
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targetingAman P Mann, Anoma Somasunderam, René Nieves-Alicea, et al.
Biochemistry|September 17, 2010
Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44Anoma Somasunderam, Varatharasa Thiviyanathan, Takemi Tanaka, et al.
Journal of Hematology & Oncology|August 31, 2013
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patientsRajendra Gharbaran, Andre Goy, Takemi Tanaka, et al.
Oncogene|February 14, 2023
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancyYingjun Ding, Junxiong Chen, Shuping Li, et al.
Molecular Imaging|February 10, 2011
Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticlesRita E Serda, Elvin Blanco, Aaron Mack, et al.
Cancer Research|September 23, 2003
A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesisLaura A Hansen, Diane Brown, Victoria Virador, et al.
Journal of Ovarian Research|April 3, 2016
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancerAyala Tamir, Anju Gangadharan, Sakshi Balwani, et al.
BMC Cancer|May 26, 2016
The effect of soluble E-selectin on tumor progression and metastasisShin-Ae Kang, Celine A Blache, Sandra Bajana, et al.
Oncotarget|June 14, 2011
Thioaptamer conjugated liposomes for tumor vasculature targetingAman P Mann, Rohan C Bhavane, Anoma Somasunderam, et al.
Pageof 5

Showing results (21-30 of 45) with videos related to

Sort By:
Pageof 5
Journal of Biomedical Materials Research. Part A|August 10, 2010
Tailoring the degradation kinetics of mesoporous silicon structures through PEGylationBiana Godin, Jianhua Gu, Rita E Serda, et al.
Plos One|October 8, 2010
Identification of thioaptamer ligand against E-selectin: potential application for inflamed vasculature targetingAman P Mann, Anoma Somasunderam, René Nieves-Alicea, et al.
Biochemistry|September 17, 2010
Combinatorial selection of DNA thioaptamers targeted to the HA binding domain of human CD44Anoma Somasunderam, Varatharasa Thiviyanathan, Takemi Tanaka, et al.
Journal of Hematology & Oncology|August 31, 2013
Fibroblast growth factor-2 (FGF2) and syndecan-1 (SDC1) are potential biomarkers for putative circulating CD15+/CD30+ cells in poor outcome Hodgkin lymphoma patientsRajendra Gharbaran, Andre Goy, Takemi Tanaka, et al.
Oncogene|February 14, 2023
EWI2 and its relatives in Tetraspanin-enriched membrane domains regulate malignancyYingjun Ding, Junxiong Chen, Shuping Li, et al.
Molecular Imaging|February 10, 2011
Proteomic analysis of serum opsonins impacting biodistribution and cellular association of porous silicon microparticlesRita E Serda, Elvin Blanco, Aaron Mack, et al.
Cancer Research|September 23, 2003
A PMLRARA transgene results in a retinoid-deficient phenotype associated with enhanced susceptibility to skin tumorigenesisLaura A Hansen, Diane Brown, Victoria Virador, et al.
Journal of Ovarian Research|April 3, 2016
The serine protease prostasin (PRSS8) is a potential biomarker for early detection of ovarian cancerAyala Tamir, Anju Gangadharan, Sakshi Balwani, et al.
BMC Cancer|May 26, 2016
The effect of soluble E-selectin on tumor progression and metastasisShin-Ae Kang, Celine A Blache, Sandra Bajana, et al.
Oncotarget|June 14, 2011
Thioaptamer conjugated liposomes for tumor vasculature targetingAman P Mann, Rohan C Bhavane, Anoma Somasunderam, et al.
Pageof 5